These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Major factors modulating the serum oxalic acid level in hemodialysis patients. Ogawa Y; Machida N; Jahana M; Gakiya M; Chinen Y; Oda M; Morozumi M; Sugaya K Front Biosci; 2004 Sep; 9():2901-8. PubMed ID: 15353324 [TBL] [Abstract][Full Text] [Related]
6. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD). Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B Nephron; 1996; 72(2):135-44. PubMed ID: 8684516 [TBL] [Abstract][Full Text] [Related]
10. Hyperoxaluria and hyperoxalemia: one more concern for the nephrologist. Mitwalli A; Oreopoulos DG Int J Artif Organs; 1985 Mar; 8(2):71-4. PubMed ID: 3886558 [No Abstract] [Full Text] [Related]
11. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia]. Stojimirović B; Grujić-Adanja G Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238 [TBL] [Abstract][Full Text] [Related]
13. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis. Ahmad S; Hatch M Nephron; 1985; 41(3):235-40. PubMed ID: 4058624 [TBL] [Abstract][Full Text] [Related]
14. Effect of hyperoxalaemia on factor VIII-related antigen in uremia. Tomson CR; Channon SM; Ward MK; Hamilton PJ; Oxley A; Laker MF Nephron; 1990; 54(3):276. PubMed ID: 2314548 [No Abstract] [Full Text] [Related]
15. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis. McConnell KN; Rolton HA; Modi KS; Macdougall AI Am J Kidney Dis; 1991 Oct; 18(4):441-5. PubMed ID: 1928062 [TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
17. [Secondary oxalosis in chronic renal insufficiency]. Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142 [TBL] [Abstract][Full Text] [Related]
18. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis. Balcke P; Schmidt P; Zazgornik J; Kopsa H; Haubenstock A Ann Intern Med; 1984 Sep; 101(3):344-5. PubMed ID: 6465702 [No Abstract] [Full Text] [Related]
19. [Oxalic acid metabolism in chronic renal failure]. Balcke P Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955 [TBL] [Abstract][Full Text] [Related]
20. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Pru C; Eaton J; Kjellstrand C Nephron; 1985; 39(2):112-6. PubMed ID: 3974772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]